A procedure for testing potential inhibitors of human chorionic gonadotrophin activity in vivo

Insights

A new in vivo method uses mouse ovaries to test human chorionic gonadotropin (hCG) inhibitors. Antiserum successfully blocked hCG activity for up to 24 hours, demonstrating the assay

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Assay development

Background:

  • Human chorionic gonadotropin (hCG) is a crucial hormone in early pregnancy.
  • Developing reliable in vivo assays for hCG inhibitors is essential for reproductive health research.
  • Ovarian hormone-responsive alkaline phosphatase offers a potential biomarker for hCG activity.

Purpose of the Study:

  • To establish and validate a novel in vivo procedure for screening potential inhibitors of hCG.
  • To utilize a hormone-responsive alkaline phosphatase in mouse ovaries as the basis for the assay.
  • To determine the efficacy of a standard antiserum in inhibiting hCG activity within a defined timeframe.

Main Methods:

  • The study employed a procedure involving young mice with hormone-responsive alkaline phosphatase in their ovaries.
  • Mice received standard injections of an antiserum.
  • A subsequent injection of 2 i.u. of hCG was administered to assess the inhibitory effect.

Main Results:

  • The developed procedure successfully demonstrated the inhibition of hCG activity in vivo.
  • The antiserum demonstrated a significant inhibitory effect on the hCG response.
  • Inhibition was observed even after an interval of up to 24 hours between antiserum and hCG administration.

Conclusions:

  • A practical and effective in vivo assay for testing hCG inhibitors has been established.
  • The assay, based on ovarian alkaline phosphatase activity, shows promise for reproductive toxicology and drug development.
  • The findings support the potential of this method for evaluating substances that modulate hCG function.